Veterinary Insulin Drugs Market

Veterinary Insulin Drugs Market : Global Industry Analysis 2015-2019 and Opportunity Assessment 2020-2030

  • Ongoing
  • July 2020
  • REP-GB-11487
  • PDF PPT EXCEL
Veterinary Insulin Drugs Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Veterinary Insulin Drugs market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Veterinary Insulin Drugs market.

Diabetes mellitus (DM), a disease experienced in larger population of animals. Diabetes among dogs, is mostly found between 4-14 years age group. Observing early symptoms of diabetes can help to control diabetes in animals. Common symptoms include, weight loss, cloudy eyes, recurring chronic infections. The recommended insulin therapy for controlling glycemic conditions include Porcine insulin zinc suspension, Vetsulin, is approved for cats and dogs. The other FDA-approved insulin, human recombinant protamine zinc insulin or PZI (Prozinc) insulin, recommended for cats only. It is considered as a long-acting insulin by clinicians in veterinary insulin drugs market. As Veterinary Insulin Drugs is focusing on advanced technology, manufacturers have designed insulin delivery devices like insulin pen for veterinary insulin drugs delivery. The modern insulin pens have reduced the cost of treatment by reducing hospital visits.

Veterinary Insulin Drugs Market: Drivers and Restraints

Rising prevalence of disease is the primary factor driving the growth of veterinary insulin drugs market. The prevalence of diabetes mellitus in dogs increased from 13.1 cases per 10,000 in 2006 to 23.6 cases per 10,000 in 2015, a 79.7 percent increase. Also increase in pet adoption is also a factor leading the growth of veterinary insulin drug market. According to a survey by American Pet Products Association 2017-2018 (APPA), 89.7 million dogs and 94.2 million cats are owned in the United States. Also, rising awareness regarding animal health and hygiene may upsurge the demand for veterinary insulin drugs market. Moreover, increasing prevalence of obesity in pets may also responsible for the rapid progress of veterinary insulin drugs market. On the other hand, lack of healthcare infrastructure for pets and awareness about the pet health may deter the growth of veterinary insulin drugs market in under developing economies.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Veterinary Insulin Drugs Market: Overview

 Among, drug type segment, long acting insulin drugs are majorly used. long acting insulin drug type is used to treat severe conditions, are expected to generate major revenue for global veterinary insulin drugs market.  Insulin delivery pens will lead the veterinary insulin drug market as the device is consumer friendly as compared to the traditional syringes. Veterinary Insulin Drugs companies are emphasizing on innovative insulin delivery device launch which has user friendly application. For instance, CANINSULIN VetPen, a Veterinary Insulin Drugs device designed by Merck, is the first Vet insulin pen for diabetic cats and dogs. Among all end user, the veterinary hospitals segment is anticipated to grow at a significant rate over the forecast period due to increasing number of veterinary infrastructures globally.

Veterinary Insulin Drugs Market: Regional Overview

North America will show the high revenue for the Veterinary Insulin Drugs market, since the people are more concerned about pet health. After North America, the Europe region will show the robust growth for veterinary insulin drugs market in the near future, due to availability of better hospital infrastructure in European countries. Latin America region will show the significant demand for the veterinary insulin drugs, due to the regional government initiative towards animal health. The Middle East and Africa are expected to be least lucrative region for veterinary insulin drugs market due to a smaller number of veterinary hospitals.

Veterinary Insulin Drugs Market: Key Players

Examples of some of the market participants in Veterinary Insulin Drugs market identified Allison Medical, Apotex Inc., Becton, Dickinson and Company, Boehringer Ingelheim Vetmedica Inc. Other players in Veterinary insulin drug market include Henry Schein Animal Health?, MED TRUST, Merck & Co.? Inc, UltiMed Inc., and Zoetis Inc and others.

The research report on Veterinary Insulin Drugs market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on Veterinary Insulin Drugs market provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on Veterinary Insulin Drugs market:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Report on Veterinary Insulin Drugs market includes regional analysis:

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Europe (Germany, Italy, France, U.K, Spain, Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, ASEAN)
  • Oceania (Australia, New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report on Veterinary Insulin Drugs market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Veterinary Insulin Drugs Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Veterinary Insulin Drugs Market: Segmentation

The global Veterinary Insulin Drugs market is classified on the basis of drug type, device, and end user.

Based on drug type, veterinary insulin drugs market is segmented into the following:

  • Rapid acting
  • Intermediate acting
  • Long acting

Based on device type, veterinary insulin drugs market is segmented into the following:

  • Insulin Delivery Pens
  • Insulin Syringes

Based on end user, veterinary insulin drugs market is segmented into the following:

  • Veterinary Clinics
  • Home Care settings
  • Veterinary Hospitals

Report on Veterinary Insulin Drugs market highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Veterinary Insulin Drugs Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Veterinary Insulin Drugs Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Akshay Godge

Akshay Godge

Client Partner - Global Business Development

Our Clients


Request Sample Request customization Request Methodology